Bidmed Pharmaceuticals: Some shareholders have collectively reduced their holdings by approximately 100,100 shares; the scheduled time period for the share reduction plan has expired.

2026-04-09 19:20:40

Abstract generation in progress

Everyday Economic News AI Express, Bijde Medical (SH 688073, closing price: 58.14 yuan) announced on the evening of April 7 that shareholders Li Yijing, Chen Jun, Li Li, Du Juan, Geng Yong, and Jiang Yamei plan to reduce their holdings of the company’s shares by the centralized bidding method within 3 months after 3 trading days from the date on which the reduction plan is disclosed, based on market conditions. The number of shares reduced will not exceed 0.95% of the company’s total share capital.

Recently, the company received a “Notice Regarding the Results of Share Reduction” letter issued by Li Yijing, Chen Jun, Geng Yong, and Jiang Yamei. Li Yijing reduced the company’s shares by 20,000 shares via centralized bidding, accounting for 0.02% of the company’s total share capital; Chen Jun reduced the company’s shares by 8,662 shares via centralized bidding, accounting for 0.01% of the company’s total share capital; Geng Yong reduced the company’s shares by approximately 44.6 thousand shares via centralized bidding, accounting for 0.05% of the company’s total share capital; Jiang Yamei reduced the company’s shares by approximately 26.9 thousand shares via centralized bidding, accounting for 0.03% of the company’s total share capital; Li Li and Du Juan did not reduce any shares. The aforementioned shareholders collectively reduced the company’s shares by approximately 100.1 thousand shares, accounting for 0.11% of the company’s total share capital. The time window for this share reduction plan has been completed.

Everyday Economic News Headline (nbdtoutiao)—Major U.S. economic data is released; the Federal Reserve’s potential interest-rate cuts this year are up in the air! Will they pivot to rate hikes? Goldman Sachs gives four reasons: “Possibility is very small.”

(Reporter Wang Xiaobo)

Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before using. The risk shall be borne by the user.

Daily Economic News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes